BrainsWay (Strategic Investor)
Strategic / Corporate InvestorJerusalem, IsraelSee on the mapbrainsway.com
neurotechmedtechmental healthmedical devices
BrainsWay is a medical technology company that develops noninvasive neurostimulation devices for mental healthcare, including its Deep TMS platform.
- 2
- Portfolio companies on reccy
- 0
- Hiring now
- 0
- Open roles in the portfolio
- Mar 2026
- Latest portfolio round
Hiring now in the portfolio0
Apply on each company's siteNone of their companies on reccy has an open role right now. Browse all neurotech roles
Portfolio on reccy2
From company funding recordsCompanyRound backedOpen roles
Their companies, round by round
From company funding records- NeuroliefNetanya, Israel
Neuromodulation
- Mar 2026Convertible Note · $6MLed
- Aug 2025Convertible Note · $5MLed
- Dec 2023Corporate Round
- Sep 2023Private Equity · $3.3M
- Dec 2022Venture Round · $6.2M
- Aug 2017Series A · $9.5M
- RadialNew York, NY
Neuromodulation
- UndatedSeries A · $50MLed
- UndatedSeed
Rounds marked Led list BrainsWay (Strategic Investor) as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Mar 2026
Neurolief · Convertible Note $6MLead
- Aug 2025
Neurolief · Convertible Note $5MLead
- Undated
Radial · Series A $50MLead
With General Catalyst, BoxGroup, Founder Collective, JSL Health Capital, Scrub Capital, Solari Capital
Portfolio in the news
From the Cortex · last 12 months- Sep 2026Radial’s Acquisition Reshapes The Brain Medicine Market
Radial · NEUROTECH FUTURES
- Jan 2026Neurolief Receives FDA PMA Approval for Proliv Rx Therapy
Neurolief · prnewswire.com
- Jan 2026Compass Pathways Establishes Strategic Collaboration with Radial
Radial · ir.compasspathways.com
- Dec 2025